日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

RBIO-14. Plasma gut microbial metabolites associate with glioblastoma risk and response to chemoradiation

RBIO-14. 血浆肠道微生物代谢物与胶质母细胞瘤风险及放化疗反应相关

Yan, Shengkun; Dong, Rong; Yang, Jiapeng; Wang, Guoqiang; Khalife, Dalya; Gorenflo, Maria; Wang, Zeneng; Wilcox, Jennifer; Behera, Tapas; Yoo, Julia; Rathi, Nityam; Shen, Alan; Brown, J Mark; Reizes, Ofer; Lathia, Justin; Hazen, Stanley; Tang, W H Wilson; Yu, Jennifer

Coarse-grained molecular dynamics investigation on the interaction between κ- and β-casein aggregates and curcumin

利用粗粒化分子动力学方法研究κ-和β-酪蛋白聚集体与姜黄素的相互作用

Gao, Jian; Dong, Rong; Yang, Shuailing; Zhao, Zhengtao; Zhang, Ye-Wang

The therapeutic value of SC66 in human renal cell carcinoma cells

SC66对人肾细胞癌细胞的治疗价值

Ming Xu #, Yin Wang #, Li-Na Zhou #, Li-Jun Xu #, Zhi-Chang Jin, Dong-Rong Yang, Min-Bin Chen, Jin Zhu

Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling

使用 miR-32-5p 通过改变 miR-32-5p/TR4/HGF/Met 信号传导来抑制透明细胞肾细胞癌转移的临床前研究

Mingchao Wang, Yin Sun, Junjie Xu, Jieyang Lu, Kefeng Wang, Dong-Rong Yang, Guosheng Yang, Gonghui Li, Chawnshang Chang

Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels

抑制去势抵抗性前列腺癌细胞中的IL-6-JAK/Stat3信号通路可通过改变PD-L1/NKG2D配体水平增强NK细胞介导的细胞毒性。

LiJun Xu ,XiaoDong Chen ,MingJing Shen ,Dong-Rong Yang ,Laifu Fang ,Guobin Weng ,Ying Tsai ,Peter C Keng ,Yuhchyau Chen ,Soo Ok Lee

Combined inhibition of JAK1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia

联合抑制JAK1,2/Stat3‑PD‑L1信号通路抑制去势抵抗性前列腺癌在缺氧条件下对NK细胞的免疫逃逸

Li-Jun Xu, Qi Ma, Jin Zhu, Jian Li, Bo-Xin Xue, Jie Gao, Chuan-Yang Sun, Ya-Chen Zang, Yi-Bin Zhou, Dong-Rong Yang, Yu-Xi Shan

ATM‑JAK‑PD‑L1 signaling pathway inhibition decreases EMT and metastasis of androgen‑independent prostate cancer

ATM‑JAK‑PD‑L1 信号通路抑制降低雄激素非依赖性前列腺癌的 EMT 和转移

Lan Zhang #, Li-Jun Xu #, Jin Zhu #, Jian Li, Bo-Xin Xue, Jie Gao, Chuan-Yang Sun, Ya-Chen Zang, Yi-Bin Zhou, Dong-Rong Yang, Yu-Xi Shan

Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals

靶向 TR4 核受体可通过改变 TIMP-1/MMP2/MMP9 信号减少浸润巨噬细胞来抑制前列腺癌侵袭

Xianfan Ding, Dong-Rong Yang, Liqun Xia, Bide Chen, Shicheng Yu, Yuanjie Niu, Mingchao Wang, Gonghui Li, Chawnshang Chang

TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression

TR4核受体通过调节EZH2相关转移基因表达来改变前列腺癌CD133+干/祖细胞的侵袭能力

Jin Zhu,Dong-Rong Yang,Yin Sun,Xiaofu Qiu,Hong-Chiang Chang,Gonghui Li,Yuxi Shan,Chawnshang Chang

The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status

抗糖尿病噻唑烷二酮对前列腺癌进展的不同影响与 TR4 核受体表达状态有关

Shin-Jen Lin, Chang-Yi Lin, Dong-Rong Yang, Kouji Izumi, Emily Yan, Xiaodan Niu, Hong-Chiang Chang, Hiroshi Miyamoto, Nancy Wang, Gonghui Li, Chawnshang Chang